Evidence map›Paper›PMID 40704794›Full record

ArticleMicrobiology spectrum2025

Early immune response to

Nadia Miranda, Oscar A Davalos, Aimy Sebastian, Margarita V Rangel, Nicole F Leon, Bria M Gorman, Deepa K Murugesh, Nicholas R Hum, Gabriela G Loots, Katrina K Hoyer and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nadia Miranda *Quantitative Systems Biology Graduate Program, University of California Merced, Merced, California, USA.
Oscar A Davalos *Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California, USA.
Aimy SebastianBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California, USA.
Margarita V RangelBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California, USA.
Nicole F LeonBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California, USA.
Bria M GormanBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California, USA.
Deepa K MurugeshBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California, USA.
Nicholas R HumBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California, USA.
Gabriela G LootsBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California, USA.
Katrina K Hoyer *Quantitative Systems Biology Graduate Program, University of California Merced, Merced, California, USA.ORCID 0000-0001-5443-0733
Dina R Weilhammer *Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California, USA.ORCID 0000-0002-7618-4702

Funding

U.S. Department of Energy 22-ERD-010
6 · The paper itself

Abstract

Coccidioidomycosis, or Valley fever, is an emerging respiratory disease caused by soil-dwelling fungi of the

Indexed as

CoccidioidesCoccidioidomycosisMacrophagesNeutrophilsAnimalsCell DifferentiationDisease Models, AnimalFemaleHost-Pathogen InteractionsLungMiceMice, Inbred C57BLCoccidioidesmacrophagesneutrophilsscRNAseqValley fever

Identifiers

PMID40704794
PMCPMC12403890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.